AU2002243391A1 - Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof - Google Patents
Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereofInfo
- Publication number
- AU2002243391A1 AU2002243391A1 AU2002243391A AU4339102A AU2002243391A1 AU 2002243391 A1 AU2002243391 A1 AU 2002243391A1 AU 2002243391 A AU2002243391 A AU 2002243391A AU 4339102 A AU4339102 A AU 4339102A AU 2002243391 A1 AU2002243391 A1 AU 2002243391A1
- Authority
- AU
- Australia
- Prior art keywords
- beta
- secretase
- methods
- antibodies
- transgenic organisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title 1
- 230000009261 transgenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24405100P | 2000-10-27 | 2000-10-27 | |
| US60/244,051 | 2000-10-27 | ||
| US70809600A | 2000-11-03 | 2000-11-03 | |
| US09/708,096 | 2000-11-03 | ||
| PCT/US2001/050771 WO2002047466A2 (en) | 2000-10-27 | 2001-10-29 | Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002243391A1 true AU2002243391A1 (en) | 2002-06-24 |
Family
ID=26936290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002243391A Abandoned AU2002243391A1 (en) | 2000-10-27 | 2001-10-29 | Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20020157122A1 (en) |
| AU (1) | AU2002243391A1 (en) |
| WO (1) | WO2002047466A2 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5138851B2 (en) * | 1999-06-28 | 2013-02-06 | オクラホマ メディカル リサーチ ファウンデーション | Catalytically active recombinant memapsin and methods of use thereof |
| US6713276B2 (en) * | 2000-06-28 | 2004-03-30 | Scios, Inc. | Modulation of Aβ levels by β-secretase BACE2 |
| WO2002068955A1 (en) * | 2001-02-23 | 2002-09-06 | Elan Pharmaceuticals, Inc. | Transgenic knockouts of bace-1 |
| WO2004029629A1 (en) * | 2002-09-27 | 2004-04-08 | Janssen Pharmaceutica N.V. | N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses |
| WO2004062627A2 (en) * | 2003-01-13 | 2004-07-29 | The Regents Of The University Of California | In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| US20060034848A1 (en) * | 2003-11-07 | 2006-02-16 | Ayae Kinoshita | Methods and compositions for treating Alzheimer's disease |
| US7906625B2 (en) * | 2005-01-24 | 2011-03-15 | Amgen Inc. | Humanized anti-amyloid antibody |
| US20060223849A1 (en) * | 2005-03-14 | 2006-10-05 | Mjalli Adnan M | Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
| US20070092517A1 (en) * | 2005-08-10 | 2007-04-26 | Oklahoma Medical Research Foundation | Truncated memapsin 2 compositions and treatments |
| EP1962584A2 (en) * | 2005-11-21 | 2008-09-03 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| CN101437933B (en) | 2005-12-28 | 2013-11-06 | 斯克里普斯研究所 | Natural antisense and non-coding RNA transcripts as drug targets |
| US8932558B2 (en) * | 2007-10-05 | 2015-01-13 | Plaxgen Inc | Multi-subunit biological complexes for treatment of plaque-associated diseases |
| CA2709354C (en) | 2007-12-21 | 2014-06-17 | Amgen Inc. | Anti-amyloid antibodies and uses thereof |
| US9908943B2 (en) | 2008-04-03 | 2018-03-06 | Vib Vzw | Single domain antibodies capable of modulating BACE activity |
| DK2281005T3 (en) | 2008-04-03 | 2014-02-24 | Vib Vzw | Single domain antibodies able to modulate bace1 activity |
| EP2143447A1 (en) * | 2008-07-11 | 2010-01-13 | Universität Konstanz | Bioconjugates comprising Aß-autoantibody-specific epitopes for active immunotherapy and diagnosis of Alzheimer's disease |
| EP2370579B1 (en) | 2008-12-04 | 2017-03-29 | CuRNA, Inc. | Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| PL2403878T3 (en) * | 2009-03-05 | 2017-12-29 | E. R. Squibb & Sons, L.L.C. | Fully human antibodies specific to cadm1 |
| JP5944822B2 (en) * | 2009-06-15 | 2016-07-05 | フエー・イー・ベー・フエー・ゼツト・ウエー | BACE1 inhibitory antibody |
| MX346500B (en) * | 2010-11-10 | 2017-03-22 | Genentech Inc * | Methods and compositions for neural disease immunotherapy. |
| US20140302532A1 (en) | 2011-04-12 | 2014-10-09 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury |
| JP2015511494A (en) | 2012-03-15 | 2015-04-20 | キュアナ,インク. | Treatment of BDNF-related diseases by inhibition of natural antisense transcripts against brain-derived neurotrophic factor (BDNF) |
| JP2015521863A (en) * | 2012-07-13 | 2015-08-03 | エル. ホルツマン,ジョーダン | Cellular and animal models for screening therapeutic agents for the treatment of Alzheimer's disease |
| KR101890978B1 (en) | 2014-06-17 | 2018-08-24 | 서울대학교산학협력단 | Transgenic cloned porcine Models for alzheimer's disease and the Use thereof |
| WO2016081640A1 (en) | 2014-11-19 | 2016-05-26 | Genentech, Inc. | Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use |
| CN107108745B (en) | 2014-11-19 | 2021-01-12 | 基因泰克公司 | Antibodies against BACE1 and their use for immunotherapy of neurological diseases |
| CN106084057A (en) * | 2016-06-13 | 2016-11-09 | 东北师范大学 | The preparation of BACE1 shearing-type high-titer antibody and application |
| JP2021508251A (en) * | 2017-11-06 | 2021-03-04 | 深▲セン▼市三▲啓▼生物技▲術▼有限公司Shenzhen Cell Inspire Biotechnology Co., Ltd. | A new human-induced pluripotent stem cell line that models Alzheimer's disease and its use |
| CN108186674B (en) * | 2018-03-22 | 2020-08-25 | 河南医学高等专科学校 | Method for establishing animal model of senile dementia and application |
| EP3932942A4 (en) * | 2019-03-01 | 2022-12-07 | Shimadzu Corporation | METHOD AND KIT FOR MEASUREMENT OF APP669-711 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE314805T1 (en) * | 1997-04-30 | 2006-02-15 | Takeda Pharmaceutical | ANIMALS CONTAINING A TRANSFERRED 25-HYDROXY-VITAMIN D3-24 HYDROXYLASE GENE |
-
2001
- 2001-10-29 AU AU2002243391A patent/AU2002243391A1/en not_active Abandoned
- 2001-10-29 WO PCT/US2001/050771 patent/WO2002047466A2/en not_active Ceased
- 2001-10-29 US US10/003,630 patent/US20020157122A1/en not_active Abandoned
-
2003
- 2003-09-04 US US10/656,624 patent/US20040132680A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002047466A2 (en) | 2002-06-20 |
| WO2002047466A3 (en) | 2003-01-23 |
| US20020157122A1 (en) | 2002-10-24 |
| US20040132680A1 (en) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002243391A1 (en) | Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof | |
| AU2001288249A1 (en) | Biosensors and methods for their use | |
| AU2001252973A1 (en) | Biosensor and related method | |
| AUPR001000A0 (en) | Novel chemical compounds and their use | |
| AU2001268590A1 (en) | Liver-specific gene expression cassettes, and methods of use | |
| AU2001277172A1 (en) | Bstp-trans protein and related reagents and methods of use thereof | |
| AU2001241474A1 (en) | Biosensor compositions and methods of use | |
| AUPR879601A0 (en) | Novel chemical compounds and their use | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2001277526A1 (en) | Substituted benzo-nitro-heterocycles and use thereof as herbicides | |
| AU2002314252A1 (en) | Chemical derivatives and the use thereof as an anti-telomerase agent | |
| AU2002220932A1 (en) | Chemical process and new intermediates | |
| AU2001278919A1 (en) | Transgenic animal and methods | |
| AU2001278011A1 (en) | Bstp-ecg1 protein and related reagents and methods of use thereof | |
| AU2001288972A1 (en) | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | |
| AU2002251140A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2001273052A1 (en) | Antifungal compounds and methods of use | |
| AU2002368056A1 (en) | Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof | |
| AU2001239246A1 (en) | Novel use of herbicides | |
| AUPR879701A0 (en) | Novel chemical compounds and their use | |
| AU2001272242A1 (en) | Portable incubator | |
| AU2002224876A1 (en) | Isolated luciferases and the use thereof | |
| AU2001264488A1 (en) | Gene expression cassette and its use | |
| AU2002237253A1 (en) | Biosensor and method of producing the same |